Alpha 2.0
Login Register
» Articles » PMID: 24506778

Antisense-mediated Exon Skipping: Networking to Meet Opportunities and to Overcome Challenges

Overview
Journal Nucleic Acid Ther
Specialties Biochemistry
Molecular Biology
Pharmacology
Date 2014 Feb 11
PMID 24506778
Citations 4
Authors
Annemieke Aartsma-Rus
Affiliations
Soon will be listed here.
Citing Articles

The bench to bedside journey of tricyclo-DNA antisense oligonucleotides for the treatment of Duchenne muscular dystrophy.

Blitek M, Phongsavanh X, Goyenvalle A RSC Med Chem. 2024; 15(9):3017-3025.

PMID: 39309360 PMC: 11411614. DOI: 10.1039/d4md00394b.

226 ENMC International Workshop:: Towards validated and qualified biomarkers for therapy development for Duchenne muscular dystrophy 20-22 January 2017, Heemskerk, The Netherlands.

Aartsma-Rus A, Ferlini A, McNally E, Spitali P, Sweeney H Neuromuscul Disord. 2017; 28(1):77-86.

PMID: 29203356 PMC: 5957286. DOI: 10.1016/j.nmd.2017.10.002.

Efficacy and Safety Profile of Tricyclo-DNA Antisense Oligonucleotides in Duchenne Muscular Dystrophy Mouse Model.

Relizani K, Griffith G, Echevarria L, Zarrouki F, Facchinetti P, Vaillend C Mol Ther Nucleic Acids. 2017; 8:144-157.

PMID: 28918017 PMC: 5498286. DOI: 10.1016/j.omtn.2017.06.013.

Splicing modulation therapy in the treatment of genetic diseases.

Arechavala-Gomeza V, Khoo B, Aartsma-Rus A Appl Clin Genet. 2014; 7:245-52.

PMID: 25506237 PMC: 4259397. DOI: 10.2147/TACG.S71506.